A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Risankizumab
Related studies linked through entity extraction aliases.
A Study to Assess How Intravenous and Subcutaneous Administrations of Risankizumab Moves Through the Body of Healthy Adult Participants
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Utilization of a Microdevice for Psoriasis and Atopic Dermatitis
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Risankizumab for Fibrostenotic Crohn's Disease Treatment
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Assess the Relative Bioavailability of Risankizumab Following Subcutaneous Administrations With a Pre-Filled Syringe or an On-Body Injector in Healthy Adult Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Assess the Bioavailability of Risankizumab Following Subcutaneous Administration With Prefilled Pen Relative to a Prefilled Syringe in Healthy Adult Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Assess the Relative Bioavailability of Risankizumab Following Subcutaneous Administration With On-Body Injector in Healthy Adult Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab
- Status
- RECRUITING
- Phase
- PHASE3
Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
- Status
- RECRUITING
- Phase
- PHASE2
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Study Participants With Active Psoriatic Arthritis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study to Assess the Relative Bioavailability of Two Formulations of Risankizumab Following Subcutaneous Administration With Prefilled Syringes in Healthy Adult Participants
- Status
- COMPLETED
- Phase
- PHASE1
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Assess Pharmacokinetic Exposures Following Intravenous and Subcutaneous Administration of Risankizumab in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Assess the Concentrations of Risankizumab in the Breast Milk of Adult Lactating Women With Inflammatory Bowel Disease
- Status
- COMPLETED
- Phase
- PHASE4
A Study to Learn How Safe and Effective Risankizumab is When Compared to Deucravacitinib to Treat Participants With Moderate Plaque Psoriasis and Who Need to Try Systemic Treatment (Works Throughout the Whole Body)
- Status
- COMPLETED
- Phase
- PHASE4
Risankizumab in Children With Crohn's Disease (RisaKids)
- Status
- RECRUITING
- Phase
- NA
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
- Status
- RECRUITING
- Phase
- PHASE3